Covered recipient · General Payments record
JIOLVER SALVADOR MARTIN ROJAS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2023–2024
$276.23
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $202.74 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $60.06 | 3 |
| Neurocrine BioSciences, Inc. | $48.93 | 2 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $28.32 | 1 |
| ABBVIE INC. | $23.27 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.10 | 1 |
| PFIZER INC. | $20.06 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.27 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104974957 | CMS |
| GlaxoSmithKline, LLC. | $23.47 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116415961 | CMS |
| GlaxoSmithKline, LLC. | $23.47 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116517838 | CMS |
| GlaxoSmithKline, LLC. | $13.12 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116329554 | CMS |
| Neurocrine Biosciences, Inc. | $22.53 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150848582 | CMS |
| Neurocrine Biosciences, Inc. | $26.40 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150835732 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.10 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119130738 | CMS |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $28.32 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118842699 | CMS |
| PFIZER INC. | $20.06 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132020735 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.